153 related articles for article (PubMed ID: 25148935)
1. The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Zhou X; Liu Y; Li D; Shi R; Kang H; Zhang J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):270-6. PubMed ID: 25148935
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Lv S; Sun B; Zhong X; Dai C; Wang W; Ma X; Song H; Shi R; Wang R
Mol Neurobiol; 2015 Aug; 52(1):555-61. PubMed ID: 25213993
[TBL] [Abstract][Full Text] [Related]
3. CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas.
Kong X; Wang Y; Liu S; Xing B; Yang Y; Li Y; Ren Z; Su C; Ma W; Wang R
Mol Neurobiol; 2016 Jul; 53(5):3503-3512. PubMed ID: 26884265
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Liu Y; Li D; Shi R; Tang Z; Fan J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):38-44. PubMed ID: 25108671
[TBL] [Abstract][Full Text] [Related]
5. Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis.
Kong X; Ma W; Li Y; Wang Y; Guan J; Gao J; Wei J; Yao Y; Lian W; Xu Z; Dou W; Xing B; Ren Z; Su C; Yang Y; Wang R
Medicine (Baltimore); 2015 Aug; 94(32):e1330. PubMed ID: 26266377
[TBL] [Abstract][Full Text] [Related]
6. The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis.
Lv S; Dai C; Liu Y; Shi R; Tang Z; Han M; Bian R; Sun B; Wang R
Mol Neurobiol; 2015; 51(3):1462-7. PubMed ID: 25063470
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
[TBL] [Abstract][Full Text] [Related]
8. Is CD147 a New Biomarker Reflecting Histological Malignancy of Gliomas?
Kong X; Wang Y; Dai C; Ma W; Wang R
Mol Neurobiol; 2017 Mar; 54(2):1568-1576. PubMed ID: 27206428
[TBL] [Abstract][Full Text] [Related]
9. CD34 Over-Expression is Associated With Gliomas' Higher WHO Grade.
Kong X; Guan J; Ma W; Li Y; Xing B; Yang Y; Wang Y; Gao J; Wei J; Yao Y; Xu Z; Dou W; Lian W; Su C; Ren Z; Wang R
Medicine (Baltimore); 2016 Feb; 95(7):e2830. PubMed ID: 26886640
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis.
Wang J; Xiang C; Cai Y; Mei Z; Lu Q; Liu B; Zou L
Arq Neuropsiquiatr; 2022 Dec; 80(12):1254-1261. PubMed ID: 36580964
[TBL] [Abstract][Full Text] [Related]
11. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between TGF- β1 expression and Treg cell infiltration in glioma].
Zhang GH; Jiang XB; Zhang XH; Sai K; Yang QY; Chen ZP; Mou YG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):680-2. PubMed ID: 21882476
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
14. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
15. The Impact of MMP-2 and Its Specific Inhibitor TIMP-2 Expression on the WHO Grade and Prognosis of Gliomas in Chinese Population: a Meta-Analysis.
Yi GZ; Feng WY; Zhou Q; Liu YW; Qi ST
Mol Neurobiol; 2017 Jan; 54(1):22-30. PubMed ID: 26729052
[TBL] [Abstract][Full Text] [Related]
16. Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis.
Zhao M; Xu H; Liang F; He J; Zhang J
Tumour Biol; 2015 Jan; 36(1):429-36. PubMed ID: 25266800
[TBL] [Abstract][Full Text] [Related]
17. Relationship between circulating inflammatory factors and glioma risk and prognosis: A meta-analysis.
Feng Y; Wang J; Tan D; Cheng P; Wu A
Cancer Med; 2019 Dec; 8(17):7454-7468. PubMed ID: 31599129
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of TGF-β in lung cancer: systematic review and meta-analysis.
Li J; Shen C; Wang X; Lai Y; Zhou K; Li P; Liu L; Che G
BMC Cancer; 2019 Jul; 19(1):691. PubMed ID: 31307405
[TBL] [Abstract][Full Text] [Related]
19. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
Ashley DM; Kong FM; Bigner DD; Hale LP
Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
[TBL] [Abstract][Full Text] [Related]
20. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]